Neogen raises revenue guidance, plans ₹600 cr QIP
Management lifts standalone revenue target to ₹950-1,050 cr; Dahej replacement plant on track for Q2 FY27; battery chemicals guidance maintained at ₹300 cr.
— 2 earlier stories on Neogen Chemicals Ltd. →What's new
- Standalone revenue guidance raised to ₹950-1,050 cr from ₹875-950 cr.
- Dahej replacement plant nearing completion, commercial production in Q2 FY27.
- Board approves ₹600 cr QIP to cut debt and fund growth.
Why this matters
The guidance upgrade signals confidence in the core chemicals business despite a stretched P/E of 178. The QIP will dilute near-term earnings but is needed to fund a capex-heavy battery chemicals strategy. Execution on Dahej and battery chemicals ramp in H2 are now the key swing factors.
What we're watching
- QIP pricing and dilution impact on equity.
- Battery chemicals revenue ramp from ₹300 cr guidance, especially in H2.
- Dahej plant commissioning timeline and cost overruns.
The full read
Neogen Chemicals raised its standalone revenue guidance for FY27 to ₹950-1,050 crore, up from ₹875-950 crore earlier, citing strong performance in its base chemicals business and the Dahej replacement plant nearing completion with commercial production slated for Q2 FY27 - an improvement over the prior February 2027 timeline flagged in May. Battery chemicals revenue guidance remains at ₹300 crore, with management expecting the ramp in the second half. That is a tall order. To fund growth and reduce debt (currently at a 0.72 debt/equity ratio) the board approved a ₹600 crore QIP. The moves show confidence, but the stock's 178x trailing P/E leaves no room for execution slip.
Questions answered
- What drove the revenue guidance upgrade?
- Management cited strong performance in organic and inorganic chemicals, raising the standalone revenue band to ₹950-1,050 cr from the earlier ₹875-950 cr.
- Is the Dahej replacement plant on schedule?
- The new Dahej plant is nearing completion and is expected to start commercial production in Q2 FY27, ahead of the prior February 2027 timeline.
- How much is Neogen raising via QIP, and why?
- The company proposes a ₹600 crore QIP to reduce debt and support growth. Neogen's debt/equity stands at 0.72, and the battery subsidiary project cost has risen to ₹1,795 crore.
- What is Neogen's battery chemicals revenue target for FY27?
- Battery chemicals revenue guidance is maintained at ₹300 crore for FY27, with the ramp expected largely in the second half.
Neogen Chemicals Ltd.
Latest quarter · Jun 2026
Strength & growth
Story so far
All notes on NEOGEN →- 27 Jul 2026 · 5:40 PM IST Neogen raises revenue guidance, plans ₹600 cr QIP
- 8d ago Neogen eyes capital raise as battery project hits ₹1,795 cr
- 64d ago Neogen's battery project cost swells 20% to ₹1,795 cr, Dahej slips to Feb 2027